Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is MAIA Biotechnology, Inc. ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-27.49%
EBIT to Interest (avg)
-16.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-2.20
Sales to Capital Employed (avg)
0
Tax Ratio
0.31%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.10%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
11.04
EV to EBIT
-2.36
EV to EBITDA
-2.36
EV to Capital Employed
-7.38
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-366.01%
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
Technical Movement
4What is working for the Company
NET PROFIT(HY)
Higher at USD -10.43 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
-8What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -15.77 MM
PRE-TAX PROFIT(Q)
Fallen at -35.82%
NET PROFIT(Q)
Fallen at -36.48%
Here's what is working for MAIA Biotechnology, Inc.
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for MAIA Biotechnology, Inc.
Operating Cash Flow
Lowest at USD -15.77 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Pre-Tax Profit
Fallen at -35.82%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Fallen at -36.48%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)






